Capella BioScience | Science
15338
page-template,page-template-full_width,page-template-full_width-php,page,page-id-15338,ajax_fade,page_not_loaded,,qode-theme-ver-13.9,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive
 

Science

Pipeline

Partnering

Capella BioScience discovers and develops mAbs both independently and in collaboration with biotechnology and academic partners.

We are employing our proprietary technologies to discover, develop and commercialise monoclonal antibody medicines to difficult and novel drug targets.

If you would like to find out more about Capella BioScience, please get in touch.